The company and its board of directors ensure the authenticity, accuracy, completeness, and no false statements or material omissions in this announcement.
Wuhan Mingde Biological Technology Co., Ltd. (hereinafter referred to as "the Company") held its fourth extraordinary general meeting on March 23, 2026, and approved the proposal regarding the share buyback plan. The buyback funds will not exceed RMB 20 million, and the buyback price shall not exceed RMB 10.00 per share. The specific buyback plan is as follows:
The buyback period is set from March 24, 2026, to June 1, 2026, and the Company will disclose the progress of the buyback on the website (http://www.cninfo.com.cn) in accordance with the announcement number 2026-013.